Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 22 Breast Neoplasms 21 Polycystic Ovary Syndrome 12 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 10 Lung Neoplasms 8 Endometrial Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Glioblastoma 5 Rectal Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Insulin Resistance 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Uterine Cervical Neoplasms 3 Leukoplakia, Oral 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Endometrial Hyperplasia 2 Diabetes Mellitus 2 Colonic Neoplasms 2

Interventions

Tamoxifen 2 Paclitaxel 2 pyrotinib 1 pembrolizumab 1 palbociclib 1 iniparib 1 darolutamide 1 Thioctic Acid 1 Pentoxifylline 1 Metformin 1 Letrozole 1 Doxorubicin 1 Cyclophosphamide 1 Capecitabine 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Female × Metformin × Clear all

NCT04170465 2022-09-10

METNEO

Damanhour University

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡